Levosimendan in Patients with Cardiogenic Shock Refractory to Dobutamine Weaning.
Zeitouni M, Dorvillius E, Sulman D, Procopi N, Beaupré F, Devos P, Barthélémy O, Rouanet S, Ferrante A, Chommeloux J, Hekimian G, Kerneis M, Silvain J, Montalescot G, ACTION Study Group
2025
PubMed
American journal of cardiovascular drugs : drugs, devices, and other interventions
